The Venture Codex Logo

The Venture Codex

Overview

Accelerating life science technology development through strategic support.

Deals ยท 12mo

2

Stage focus

Series A
Series B

Geographic focus

Canada
United States

Sector focus

Biopharma
Biotechnology
Health Care
Information Technology

Investment portfolio

21rounds
NAMEDATESIZE
Crystalys Therapeutics
Jul 2026Participated
$130 MSeries B
CereVasc
Jun 2026Participated
$85 MSeries C
Crystalys Therapeutics
Sep 2025Participated
$205 MSeries A
Mercy BioAnalytics
Sep 2025Participated
$59 MSeries B
Galvanize Therapeutics
Sep 2025Participated
$100 MSeries C
Zucara Therapeutics
May 2025Participated
$25 MSeries B
Merida Biosciences
Apr 2025Participated
$121 MSeries A
CereVasc
May 2024Led
$70 MSeries B
Adaptilens
Apr 2024Led
$18 MSeries A
TORL BioTherapeutics
Apr 2024Participated
$158 MSeries B
Avalyn Pharma
Sep 2023Led
$175 MSeries C
A-Alpha Bio
Jul 2023Led
$22 MSeries A
Crystalys Therapeutics
Jul 2026Participated
$130 MSeries B
CereVasc
Jun 2026Participated
$85 MSeries C
Crystalys Therapeutics
Sep 2025Participated
$205 MSeries A
Mercy BioAnalytics
Sep 2025Participated
$59 MSeries B
Galvanize Therapeutics
Sep 2025Participated
$100 MSeries C
Zucara Therapeutics
May 2025Participated
$25 MSeries B
Merida Biosciences
Apr 2025Participated
$121 MSeries A
CereVasc
May 2024Led
$70 MSeries B
Adaptilens
Apr 2024Led
$18 MSeries A
TORL BioTherapeutics
Apr 2024Participated
$158 MSeries B
Avalyn Pharma
Sep 2023Led
$175 MSeries C
A-Alpha Bio
Jul 2023Led
$22 MSeries A
21
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Perceptive Xontogeny Venture Fund: 21 funding rounds are recorded in the selected participation categories.All available history.
Perceptive Xontogeny Venture Fund: 21 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A84
Series B15
Series C+12

Monthly Deal Activity

Perceptive Xontogeny Venture Fund: 21 deals are recorded across 80 months.All available history.
Perceptive Xontogeny Venture Fund: 21 deals are recorded across 80 months. All available history
MonthDeals
Mar '201
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '211
Dec '210
Jan '222
Feb '220
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '231
Apr '231
May '230
Jun '231
Jul '231
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '242
May '241
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '251
May '251
Jun '250
Jul '250
Aug '250
Sep '253
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '261
Aug '260
Sep '260
Oct '260

Sector Breakdown

Perceptive Xontogeny Venture Fund: Health & Life Sciences is the largest displayed sector by deal count (21 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Perceptive Xontogeny Venture Fund: Health & Life Sciences is the largest displayed sector by deal count (21 deals). All available history
SectorDeals
Health & Life Sciences21
Space & Frontier Tech2

Deal Size Distribution

Perceptive Xontogeny Venture Fund: 21 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Perceptive Xontogeny Venture Fund: 21 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M4
$25M-$50M5
$50M-$100M4
$100M-$250M8
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Perceptive Xontogeny Venture Fund: United States has the largest recorded deal count among the displayed regions (19 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Perceptive Xontogeny Venture Fund: United States has the largest recorded deal count among the displayed regions (19 deals). All available history
RegionDeals
United States19
Canada2
Perceptive Xontogeny Venture Fund: 20 co-investors are shown, with Alexandria Venture Investments sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Perceptive Xontogeny Venture Fund: Led accounts for 48% and participating for 52% of round participation.All available history.
Perceptive Xontogeny Venture Fund: Led accounts for 48% and participating for 52% of round participation. All available history
CategoryDeals (count)Share (%)
Led1048%
Participating1152%
Perceptive Xontogeny Venture Fund: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Perceptive Xontogeny Venture Fund: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead550%
Co-led550%

Team

ADAM STONE

Director

Chris Garabedian

Chairman & CEO

Takeru Furuya

Principal